Showing results (381-390 of 491) with videos related to

Sort By:
Pageof 50
Clinical Transplantation|March 6, 2024
Use of induction therapy post-heart transplantation: Clinical practice recommendations based on systematic review and network meta-analysis of evidenceFarid Foroutan, Gordon Guyatt, Josef Stehlik, et al.
Vaccine|September 29, 2023
Implementation of a vaccination clinic for adult solid organ transplant candidates: A single-center experienceZitta Barrella Harboe, Annemette Hald, Christina Ekenberg, et al.
JACC. Heart Failure|March 11, 2019
Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection FractionEmil Wolsk, David Kaye, Jan Komtebedde, et al.
Clinical Transplantation|May 8, 2024
Induction therapy in heart transplantation: A systematic review and network meta-analysis for developing evidence-based recommendationsLakshmi Kugathasan, Daniel G Rayner, Sabrina Mianchen Wang, et al.
European Journal of Heart Failure|May 5, 2026
Update on heart transplantation: a clinical consensus statement of the Advanced Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyDavor Milicic, Ivo Planinc, Stamatis Adamopoulos, et al.
JACC. Advances|July 23, 2026
Short-Term Effects of Pecavaptan on Weight and Congestion in Acute Heart Failure: The AVANTI Post-Hoc AnalysisDaan C H Ceelen, Geert H D Voordes, Lucija Cosic, et al.
European Journal of Heart Failure|May 11, 2024
New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trialMunise N Karacan, Seiko N Doi, Adelina Yafasova, et al.
Journal of Cardiac Failure|May 16, 2024
Effect of Implantable Cardioverter-defibrillators in Nonischemic Heart Failure According to Background Medical Therapy: Extended Follow-up of the DANISH TrialAdelina Yafasova, Seiko N Doi, Jens Jakob Thune, et al.
American Heart Journal|August 18, 2020
Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
ESC Heart Failure|January 20, 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIREMarcin Ufnal, Kathleen Connolly, Marcus Millegard, et al.
Pageof 50